iRhythm Holdings, Inc. (IRTC)
150.96
-7.92
(-4.98%)
USD |
NASDAQ |
Feb 20, 16:00
151.13
+0.17
(+0.11%)
After-Hours: 20:00
iRhythm Holdings Research and Development Expense (Quarterly) : 21.05M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 46.07M |
| Alphatec Holdings, Inc. | 18.68M |
| AtriCure, Inc. | 22.74M |
| Baxter International, Inc. | 116.00M |
| Integra LifeSciences Holdings Corp. | 20.42M |